LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.1
 51.33 27.76 1164 5117 0.2275 0.6428
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 51.33 27.76 1192 5117 0.2330 0.6480
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 51.33 27.76 1292 5117 0.2525 0.6657
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 51.33 27.76 1306 5117 0.2552 0.6681
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 53.04 27.76 1146 5365 0.2136 0.6321
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 53.04 27.76 1181 5365 0.2201 0.6386
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 53.04 27.76 1276 5365 0.2378 0.6554
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 53.04 27.76 1299 5365 0.2421 0.6593
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 54.74 27.76 1168 5606 0.2083 0.6296
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 54.74 27.76 1200 5606 0.2140 0.6353
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 54.74 27.76 1331 5606 0.2374 0.6576
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 54.74 27.76 1349 5606 0.2406 0.6605
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 56.45 27.76 1172 5745 0.2040 0.6266
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 56.45 27.76 1211 5745 0.2108 0.6336
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 56.45 27.76 1281 5745 0.2230 0.6456
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 56.45 27.76 1305 5745 0.2271 0.6495
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 58.15 27.76 1167 5906 0.1976 0.6217
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 58.15 27.76 1204 5906 0.2038 0.6282
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 58.15 27.76 1349 5906 0.2284 0.6523
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 58.15 27.76 1374 5906 0.2326 0.6563
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 59.85 27.76 1202 6062 0.1983 0.6240
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 59.85 27.76 1232 6062 0.2032 0.6292
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 59.85 27.76 1353 6062 0.2232 0.6490
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 59.85 27.76 1380 6062 0.2276 0.6532
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 61.56 27.76 1198 6217 0.1927 0.6197
MN20160318_Q01
L03